Current Advances and Future Directions of Pluripotent Stem Cells-Derived Engineered Heart Tissue for Treatment of Cardiovascular Diseases is a research paper published in Cells (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01HL157456
National Institutes of Health
Grant: R01HL168464
National Institutes of Health
Grant: R01HL167670
National Institutes of Health
Grant: R01HL171495
National Institutes of Health
Grant: 968781
NIH HHS
Grant: 1R01HL168464-01A1
NIH HHS
Grant: 1R01HL157456-04A1
NIH HHS
Grant: 1R01HL171495-01A1
NIH HHS
Grant: 1R01HL167670-01A1
National Institutes of Health
Grant: 5R01HL168464-02
A novel strategy for heart failure therapeutics
National Institutes of Health
Grant: 7R01HL171495-02
Alleviation of chemotherapy-induced cardiovascular toxicity
National Institutes of Health
Grant: 5R01HL157456-04
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction
National Institutes of Health
Grant: 5R01HL167670-02
Sex-Specific Roles of L-PK in Cholesterol Metabolism and Atherosclerosis
FWCI
3.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals